These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12559936)

  • 1. A sensitive test for early myocardial iron loading.
    Hoffband AV
    Eur Heart J; 2003 Jan; 24(1):26-7. PubMed ID: 12559936
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cardiac iron overload in thalassemia major.
    Westwood M; Anderson LJ; Pennell DJ
    Haematologica; 2003 May; 88(5):481-2. PubMed ID: 12745264
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
    Tanner MA; Galanello R; Dessi C; Westwood MA; Smith GC; Nair SV; Anderson LJ; Walker JM; Pennell DJ
    J Cardiovasc Magn Reson; 2006; 8(3):543-7. PubMed ID: 16755844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
    Saliba AN; El Rassi F; Taher AT
    Expert Rev Hematol; 2016; 9(2):151-68. PubMed ID: 26613264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of myocardial iron overload using cardiovascular magnetic resonance imaging.
    Mavrogeni S; Pepe A; Lombardi M
    Hellenic J Cardiol; 2011; 52(5):385-90. PubMed ID: 21940285
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload.
    Vogel M; Anderson LJ; Holden S; Deanfield JE; Pennell DJ; Walker JM
    Eur Heart J; 2003 Jan; 24(1):113-9. PubMed ID: 12559943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme cardiac iron loading in transfusion-dependent thalassaemia major: cardiac T2* and T1 mapping guiding treatment.
    Brown RA; Moon JC; Telfer PT; Khanji MY
    Eur Heart J; 2019 Nov; 40(43):3578. PubMed ID: 30879023
    [No Abstract]   [Full Text] [Related]  

  • 9. [Magnetic resonance imaging evidence of the effectiveness of combination chelation therapy in iron overload cardiomyopathy].
    Martín M; Estornell J; Orero M; Pérez JL; Ridocci F; Martínez V
    Rev Esp Cardiol; 2006 Jan; 59(1):75-7. PubMed ID: 16434009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled study evaluating effects of amlodipine addition to chelators to reduce iron loading in patients with thalassemia major.
    Eghbali A; Kazemi H; Taherahmadi H; Ghandi Y; Rafiei M; Bagheri B
    Eur J Haematol; 2017 Dec; 99(6):577-581. PubMed ID: 28960482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network.
    Pepe A; Meloni A; Filosa A; Pistoia L; Borsellino Z; D'Ascola DG; Lisi R; Putti MC; Allò M; Gamberini MR; Quarta A; Fidone C; Casini T; Restaino G; Midiri M; Mangione M; Positano V; Casale M
    JACC Cardiovasc Imaging; 2020 May; 13(5):1284-1286. PubMed ID: 32061556
    [No Abstract]   [Full Text] [Related]  

  • 12. Purging iron from the heart.
    Hershko C; Cappellini MD; Galanello R; Piga A; Tognoni G; Masera G
    Br J Haematol; 2004 Jun; 125(5):545-51. PubMed ID: 15147368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR quantitative susceptibility imaging for the evaluation of iron loading in the brains of patients with β-thalassemia major.
    Qiu D; Chan GC; Chu J; Chan Q; Ha SY; Moseley ME; Khong PL
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1085-90. PubMed ID: 24578278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract]   [Full Text] [Related]  

  • 15. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
    Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
    Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future treatment strategies for iron overload cardiomyopathy.
    Wongjaikam S; Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Eur J Pharmacol; 2015 Oct; 765():86-93. PubMed ID: 26291660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2* magnetic resonance and myocardial iron in thalassemia.
    Pennell DJ
    Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide as marker of myocardial iron load in beta-thalassemia.
    Nikolidakis S; Flessa C; Nikolaou N; Gotsis ED; Koutouzis M; Polyhronaki E; Vrettou E; Kyriakides ZS
    Int J Cardiol; 2007 Jun; 118(3):408-9. PubMed ID: 17045671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary iron overload in thalassemia major presenting as small airway disease.
    Ooi GC; Khong PL; Lam WK; Trendell-Smith NJ; Tsang KW
    Acta Haematol; 2002; 108(1):43-6. PubMed ID: 12145467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.